- Home
- OZ vs STIM Comparison
OZ vs STIM Comparison
Compare OZ & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZ
- STIM
- Stock Information
- Founded
- OZ 2020
- STIM 2003
- Country
- OZ United States
- STIM United States
- Employees
- OZ N/A
- STIM N/A
- Industry
- OZ
- STIM Medical/Dental Instruments
- Sector
- OZ
- STIM Health Care
- Exchange
- OZ Nasdaq
- STIM Nasdaq
- Market Cap
- OZ 236.3M
- STIM 232.3M
- IPO Year
- OZ N/A
- STIM 2018
- Fundamental
- Price
- OZ $63.75
- STIM $4.43
- Analyst Decision
- OZ
- STIM Buy
- Analyst Count
- OZ 0
- STIM 4
- Target Price
- OZ N/A
- STIM $6.00
- AVG Volume (30 Days)
- OZ 6.0K
- STIM 792.7K
- Earning Date
- OZ 01-01-0001
- STIM 05-06-2025
- Dividend Yield
- OZ N/A
- STIM N/A
- EPS Growth
- OZ N/A
- STIM N/A
- EPS
- OZ N/A
- STIM N/A
- Revenue
- OZ $2,675,000.00
- STIM $89,448,000.00
- Revenue This Year
- OZ N/A
- STIM $102.36
- Revenue Next Year
- OZ N/A
- STIM $9.83
- P/E Ratio
- OZ N/A
- STIM N/A
- Revenue Growth
- OZ 18.68
- STIM 22.16
- 52 Week Low
- OZ $56.77
- STIM $0.52
- 52 Week High
- OZ $82.89
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- OZ 53.29
- STIM 54.83
- Support Level
- OZ $62.95
- STIM $3.30
- Resistance Level
- OZ $64.50
- STIM $4.82
- Average True Range (ATR)
- OZ 0.96
- STIM 0.32
- MACD
- OZ 0.31
- STIM 0.03
- Stochastic Oscillator
- OZ 78.43
- STIM 74.59
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.